How much revenue did BioLife Solutions generate this year?
BioLife Solutions has achieved a revenue of 110.08 M USD this year.
BioLife Solutions Revenue 2024
BioLife Solutions Revenue
110.08 M USD
Ticker
BLFS
ISIN
US09062W2044
WKN
A1XCF2
In 2024, BioLife Solutions's sales reached 110.08 M USD, a -23.17% difference from the 143.27 M USD sales recorded in the previous year.
The BioLife Solutions Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 356.56 | 13,11 |
| 2028e | 280.81 | 16,65 |
| 2027e | 220.03 | 21,25 |
| 2026e | 152.37 | 30,68 |
| 2025e | 123.93 | 37,72 |
| 2024e | 110.08 | 42,47 |
| 2023 | 143.27 | 32,63 |
| 2022 | 161.8 | 33,25 |
| 2021 | 119.2 | 31,04 |
| 2020 | 48.1 | 56,96 |
| 2019 | 27.4 | 67,88 |
| 2018 | 19.7 | 68,53 |
| 2017 | 11 | 60,91 |
| 2016 | 8.2 | 58,54 |
| 2015 | 6.4 | 59,37 |
| 2014 | 6.2 | 48,39 |
| 2013 | 8.9 | 42,70 |
| 2012 | 5.7 | 40,35 |
| 2011 | 2.8 | 50,00 |
| 2010 | 2.1 | 42,86 |
| 2009 | 1.6 | 37,50 |
| 2008 | 1.3 | 46,15 |
| 2007 | 1 | 50,00 |
| 2006 | 0.6 | 50,00 |
| 2005 | 0.6 | 66,67 |
| 2004 | 0.6 | 83,33 |
BioLife Solutions Revenue, EBIT, Net Income US09062W2044 · A1XCF2
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into BioLife Solutions, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BioLife Solutions from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BioLife Solutions’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of BioLife Solutions. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into BioLife Solutions’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing BioLife Solutions’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BioLife Solutions’s growth potential.
BioLife Solutions Revenue, Profit, and EBIT History
| Date | BioLife Solutions Revenue | BioLife Solutions EBIT | BioLife Solutions Net Income |
|---|---|---|---|
| 2029e | 356.56 M USD | 0 USD | 0 USD |
| 2028e | 280.81 M USD | 33.42 M USD | 0 USD |
| 2027e | 220.03 M USD | 19.81 M USD | 0 USD |
| 2026e | 152.37 M USD | 2.68 M USD | -7.04 M USD |
| 2025e | 123.93 M USD | -16.81 M USD | -17.18 M USD |
| 2024e | 110.08 M USD | -22.95 M USD | -25.96 M USD |
| 2023 | 143.27 M USD | -55.34 M USD | -66.43 M USD |
| 2022 | 161.8 M USD | -35.1 M USD | -139.8 M USD |
| 2021 | 119.2 M USD | -33.5 M USD | -8.9 M USD |
| 2020 | 48.1 M USD | -5.5 M USD | 1.8 M USD |
| 2019 | 27.4 M USD | 700,000 USD | -1.7 M USD |
| 2018 | 19.7 M USD | 3.7 M USD | -25.3 M USD |
| 2017 | 11 M USD | -1.1 M USD | -2.7 M USD |
| 2016 | 8.2 M USD | -4.9 M USD | -6.9 M USD |
| 2015 | 6.4 M USD | -5 M USD | -4.2 M USD |
| 2014 | 6.2 M USD | -3.1 M USD | -3.2 M USD |
| 2013 | 8.9 M USD | -300,000 USD | -1.1 M USD |
| 2012 | 5.7 M USD | -900,000 USD | -1.7 M USD |
| 2011 | 2.8 M USD | -1.2 M USD | -2 M USD |
| 2010 | 2.1 M USD | -1.4 M USD | -2 M USD |
| 2009 | 1.6 M USD | -1.9 M USD | -2.8 M USD |
| 2008 | 1.3 M USD | -2.2 M USD | -2.8 M USD |
| 2007 | 1 M USD | -2.5 M USD | -2.9 M USD |
| 2006 | 600,000 USD | -1.5 M USD | -1.1 M USD |
| 2005 | 600,000 USD | -600,000 USD | -600,000 USD |
| 2004 | 600,000 USD | -700,000 USD | -700,000 USD |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 600,000 USD | -700,000 USD | -700,000 USD |
| 2005 | 600,000 USD | -600,000 USD | -600,000 USD |
| 2006 | 600,000 USD | -1.5 M USD | -1.1 M USD |
| 2007 | 1 M USD | -2.5 M USD | -2.9 M USD |
| 2008 | 1.3 M USD | -2.2 M USD | -2.8 M USD |
| 2009 | 1.6 M USD | -1.9 M USD | -2.8 M USD |
| 2010 | 2.1 M USD | -1.4 M USD | -2 M USD |
| 2011 | 2.8 M USD | -1.2 M USD | -2 M USD |
| 2012 | 5.7 M USD | -900,000 USD | -1.7 M USD |
| 2013 | 8.9 M USD | -300,000 USD | -1.1 M USD |
| 2014 | 6.2 M USD | -3.1 M USD | -3.2 M USD |
| 2015 | 6.4 M USD | -5 M USD | -4.2 M USD |
| 2016 | 8.2 M USD | -4.9 M USD | -6.9 M USD |
| 2017 | 11 M USD | -1.1 M USD | -2.7 M USD |
| 2018 | 19.7 M USD | 3.7 M USD | -25.3 M USD |
| 2019 | 27.4 M USD | 700,000 USD | -1.7 M USD |
| 2020 | 48.1 M USD | -5.5 M USD | 1.8 M USD |
| 2021 | 119.2 M USD | -33.5 M USD | -8.9 M USD |
| 2022 | 161.8 M USD | -35.1 M USD | -139.8 M USD |
| 2023 | 143.27 M USD | -55.34 M USD | -66.43 M USD |
| 2024e | 110.08 M USD | -22.95 M USD | -25.96 M USD |
| 2025e | 123.93 M USD | -16.81 M USD | -17.18 M USD |
| 2026e | 152.37 M USD | 2.68 M USD | -7.04 M USD |
| 2027e | 220.03 M USD | 19.81 M USD | 0 USD |
| 2028e | 280.81 M USD | 33.42 M USD | 0 USD |
| 2029e | 356.56 M USD | 0 USD | 0 USD |
BioLife Solutions stock margins US09062W2044 · A1XCF2
The BioLife Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioLife Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioLife Solutions.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the BioLife Solutions's sales revenue. A higher gross margin percentage indicates that the BioLife Solutions retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the BioLife Solutions's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the BioLife Solutions's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BioLife Solutions's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BioLife Solutions. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BioLife Solutions's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
BioLife Solutions Margin History
| BioLife Solutions Gross margin | BioLife Solutions Profit margin | BioLife Solutions EBIT margin | BioLife Solutions Profit margin |
|---|---|---|---|
| 2029e | 32.63 % | 0 % | 0 % |
| 2028e | 32.63 % | 11.9 % | 0 % |
| 2027e | 32.63 % | 9 % | 0 % |
| 2026e | 32.63 % | 1.76 % | -4.62 % |
| 2025e | 32.63 % | -13.56 % | -13.87 % |
| 2024e | 32.63 % | -20.84 % | -23.58 % |
| 2023 | 32.63 % | -38.63 % | -46.36 % |
| 2022 | 33.25 % | -21.69 % | -86.4 % |
| 2021 | 31.04 % | -28.1 % | -7.47 % |
| 2020 | 56.96 % | -11.43 % | 3.74 % |
| 2019 | 67.88 % | 2.55 % | -6.2 % |
| 2018 | 68.53 % | 18.78 % | -128.43 % |
| 2017 | 60.91 % | -10 % | -24.55 % |
| 2016 | 58.54 % | -59.76 % | -84.15 % |
| 2015 | 59.38 % | -78.13 % | -65.62 % |
| 2014 | 48.39 % | -50 % | -51.61 % |
| 2013 | 42.7 % | -3.37 % | -12.36 % |
| 2012 | 40.35 % | -15.79 % | -29.82 % |
| 2011 | 50 % | -42.86 % | -71.43 % |
| 2010 | 42.86 % | -66.67 % | -95.24 % |
| 2009 | 37.5 % | -118.75 % | -175 % |
| 2008 | 46.15 % | -169.23 % | -215.38 % |
| 2007 | 50 % | -250 % | -290 % |
| 2006 | 50 % | -250 % | -183.33 % |
| 2005 | 66.67 % | -100 % | -100 % |
| 2004 | 83.33 % | -116.67 % | -116.67 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 83.33 % | -116.67 % | -116.67 % |
| 2005 | 66.67 % | -100 % | -100 % |
| 2006 | 50 % | -250 % | -183.33 % |
| 2007 | 50 % | -250 % | -290 % |
| 2008 | 46.15 % | -169.23 % | -215.38 % |
| 2009 | 37.5 % | -118.75 % | -175 % |
| 2010 | 42.86 % | -66.67 % | -95.24 % |
| 2011 | 50 % | -42.86 % | -71.43 % |
| 2012 | 40.35 % | -15.79 % | -29.82 % |
| 2013 | 42.7 % | -3.37 % | -12.36 % |
| 2014 | 48.39 % | -50 % | -51.61 % |
| 2015 | 59.38 % | -78.13 % | -65.62 % |
| 2016 | 58.54 % | -59.76 % | -84.15 % |
| 2017 | 60.91 % | -10 % | -24.55 % |
| 2018 | 68.53 % | 18.78 % | -128.43 % |
| 2019 | 67.88 % | 2.55 % | -6.2 % |
| 2020 | 56.96 % | -11.43 % | 3.74 % |
| 2021 | 31.04 % | -28.1 % | -7.47 % |
| 2022 | 33.25 % | -21.69 % | -86.4 % |
| 2023 | 32.63 % | -38.63 % | -46.36 % |
| 2024e | 32.63 % | -20.84 % | -23.58 % |
| 2025e | 32.63 % | -13.56 % | -13.87 % |
| 2026e | 32.63 % | 1.76 % | -4.62 % |
| 2027e | 32.63 % | 9 % | 0 % |
| 2028e | 32.63 % | 11.9 % | 0 % |
| 2029e | 32.63 % | 0 % | 0 % |
BioLife Solutions Aktienanalyse
What does BioLife Solutions do?
BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry. BioLife Solutions ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding BioLife Solutions's Sales Figures
The sales figures of BioLife Solutions originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing BioLife Solutions’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize BioLife Solutions's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in BioLife Solutions’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about BioLife Solutions Stock
How much was the turnover of the company BioLife Solutions compared to the previous year?
The revenue of BioLife Solutions has increased by -23.17% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of BioLife Solutions?
The revenue of BioLife Solutions is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of BioLife Solutions measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of BioLife Solutions so important for investors?
The revenue of BioLife Solutions is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does BioLife Solutions pay?
Over the past 12 months, BioLife Solutions paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioLife Solutions is expected to pay a dividend of 0 USD.
What is the dividend yield of BioLife Solutions?
The current dividend yield of BioLife Solutions is .
When does BioLife Solutions pay dividends?
BioLife Solutions pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BioLife Solutions?
BioLife Solutions paid dividends every year for the past 0 years.
What is the dividend of BioLife Solutions?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BioLife Solutions located?
BioLife Solutions is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioLife Solutions kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioLife Solutions from 6/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.
When did BioLife Solutions pay the last dividend?
The last dividend was paid out on 6/19/2024.
What was the dividend of BioLife Solutions in the year 2023?
In the year 2023, BioLife Solutions distributed 0 USD as dividends.
In which currency does BioLife Solutions pay out the dividend?
The dividends of BioLife Solutions are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The BioLife Solutions stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von BioLife Solutions
Our stock analysis for BioLife Solutions Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioLife Solutions Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- BioLife Solutions Revenue
- BioLife Solutions Net Income
- BioLife Solutions P/E
- BioLife Solutions P/S
- BioLife Solutions EBIT
- BioLife Solutions Dividend
- BioLife Solutions Stocks
- BioLife Solutions Market capitalization
- BioLife Solutions Debt
- BioLife Solutions Liabilities
- BioLife Solutions Equity
- BioLife Solutions AAQS
- BioLife Solutions Employees
- BioLife Solutions ROE
- BioLife Solutions ROA
- BioLife Solutions ROCE
